Efficacy of inhaled tiotropium in patients with airflow limitation after pulmonary resection for lung cancer

Efficacy of inhaled tiotropium in patients with airflow limitation after pulmonary resection for lung cancer - Efficacy of tiotropium in patients with airflow limitation after lung cancer surgery

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006652

Enrollment

200

Registered

2011-11-02

Start date

2007-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Tiotropium group Control group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Lung cancer patients with airflow limitation

Exclusion criteria

Exclusion criteria: Administration contraindication in inhaled tiotropium

Design outcomes

Primary

Measure	Time frame
Incidence of postoperative cardiopulmonary complications	—

Secondary

Measure	Time frame
Perioperative changes of white blood cell counts and C-reactive protein levels after surgery Pulmonary functions after surgery Lung cancer recurrence after surgery	—

Countries

Japan

Contacts

Public ContactTakashi Nojiri

National Cerebral Cardiovascular Center Research Institute Biochemistry

nojiri@ri.ncvc.go.jp06-6833-5012

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026